Apellis Pharmaceuticals Aktie
22,98
EUR
-0,40
EUR
-1,71
%
27,32
USD
+1,04
USD
+3,96
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
| 01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
| 24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung